Inflammation, metaflammation and immunometabolic disorders
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Proper regulation and management of energy, substrate diversity and quantity, as well as macromolecular synthesis and breakdown processes, are fundamental to cellular and organismal survival and are paramount to health. Cellular and multicellular organization are defended by the immune response, a robust and critical system through which self is distinguished from non-self, pathogenic signals are recognized and eliminated, and tissue homeostasis is safeguarded. Many layers of evolutionarily conserved interactions occur between immune response and metabolism. Proper maintenance of this delicate balance is crucial for health and has important implications for many pathological states such as obesity, diabetes, and other chronic non-communicable diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypertrophic visceral adipose tissue is a primary driver of chronic, low-grade meta-inflammation, characterized by an accelerated secretion of pro-inflammatory cytokines (such as TNF-alpha and IL-6) and a concomitant reduction in protective adiponectin [9,11,12].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Excess visceral adiposity does not merely represent a passive energy reserve; rather, it acts as an active immunometabolic organ [8-10].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Inflammageing is now being recognized as a hallmark of ageing and a key driver of disease (FIG. 3Aa), including ageing-associated diseases, and has been described as a prominent risk factor for morbidity and death95–97.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“Chronic inflammation has profound effects on systemic metabolism, via a complicated crosstalk between immune cells and metabolic cells, such as hepatocytes and adipocytes, influencing metabolic processes such as glucose and lipid uptake, and insulin sensitivity96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“For example, in obese tissues such as the visceral fat, peripheral monocytes are recruited by stressed adipocytes, leading to a progressive infiltration of proinflammatory M1-like macrophages and the displacement of the resident, anti-inflammatory M2 macrophages96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Collino, M., Benetti, E., Rogazzo, M., Chiazza, F., Mastrocola, R., Nigro, D., Cutrìn, J. C., Aragno, M., Fantozzi, R., Minetto, M. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12888 · Cited by 25
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Cited by
Items 301–400 of 1,004
Fernandez, S., Viola, J. M., Torres, A., Wallace, M., Trefely, S., Zhao, S., Affronti, H. C., Gengatharan, J. M., Guertin, D. A., Snyder, N. W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.112 · Cited by 80
“Inflammation within WAT can contribute to metabolic dysfunction (Hotamisligil, 2017), and we noted that adipocyte size was more heterogeneous in ACLY-deficient SWAT and pgWAT and that there was evidence for increased presence of non-adipocyte cell types (Figure 4A).”
BackgroundThe Role of Autophagy in White Adipose Tissue Function: Implications for Metabolic Health
Clemente‐Postigo, M., Tinahones, A., Bekay, R. E., Malagón, M. M., & Tinahones, F. J. (2020) · Metabolites · doi:10.3390/metabo10050179 · Cited by 83
“Local and systemic low-grade inflammatory state is another hallmark of metabolic dysregulation [28,169,171,182].”
BackgroundInnate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis
Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., & Bruno, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197165 · Cited by 78
“Chronic pathological disorders, including cardiovascular diseases (CVDs) [1,2], neurodegenerative diseases [3,4], diabetes [5,6], metabolic syndrome [7,8], and cancer [9,10] share an inflammatory microenvironment as a hallmark [11].”
BackgroundBatista, A. F., Bodart‐Santos, V., Felice, F. G. D., & Ferreira, S. T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0593-6 · Cited by 77
Type I interferon sensing unlocks dormant adipocyte inflammatory potential
Chan, C. C., Damen, M. S. M. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Alarcon, P. C., Oates, J. R., Doll, J. R., Mukherjee, R., Chen, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16571-4 · Cited by 78
Tomé, D. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00164-1 · Cited by 80
“These processes include for a part a series of complex interactions between immune functions and metabolic pathways resulting from a convergent evolution of the two systems [1, 2].”
BackgroundXu, D., Wu, Q.-Y., Liu, W., Hu, G., Meng, H., & Wang, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125919 · Cited by 79
Plant-Based Fat, Dietary Patterns Rich in Vegetable Fat and Gut Microbiota Modulation
Muralidharan, J., Galié, S., Hernández‐Alonso, P., Bulló, M., & Salas‐Salvadó, J. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00157 · Cited by 86
“Both these results indicate that fish oil could potentially increase the risk of inflammation, contrary to the prior studies (79).”
ResultInfluence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients
Frasca, D., Reidy, L. J., Cray, C., Diaz, A., Romero, M., Kahl, K. W., & Blomberg, B. B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245424 · Cited by 83
“This result is consistent with the knowledge that obesity is an inflammatory condition associated with inflammaging [1] and metaflammation [50] both of which are negatively associated with a functional immune system [51].”
ResultAnti-Inflammatory Diets in Fertility: An Evidence Review
Alesi, S., Villani, A. M., Mantzioris, E., Takele, W. W., Cowan, S., Moran, L., & Mousa, A. (2022) · Nutrients · doi:10.3390/nu14193914 · Cited by 80
Lonardo, A., Mantovani, A., Targher, G., & Baffy, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113320 · Cited by 86
“Given that ‘metaflammation’ [81] plays a key role in progressive liver injury, it is reasonable to postulate that a hepatic environment rich in immune cells can modulate NAFLD development and severity [82].”
BackgroundDifferences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes
Herder, C., Maalmi, H., Strassburger, K., Zaharia, O.-P., Ratter, J. M., Karusheva, Y., Elhadad, M. A., Bódis, K., Bongaerts, B. W. C., Rathmann, W., et al. (2021) · Diabetes · doi:10.2337/db20-1054 · Cited by 73
Chen, H., Yang, H., Deng, J., & Fan, D. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07805 · Cited by 77
CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder
Wang, X., Liu, M., Zhang, J., Brown, N. K., Zhang, P., Zhang, Y., Liu, H., Du, X., Wu, W., Devenport, M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.07.005 · Cited by 74
Kenđel Jovanović, G., Mrakovcic-Sutic, I., Pavičić Žeželj, S., Šuša, B., Rahelić, D., & Klobučar Majanović, S. (2020) · Nutrients · doi:10.3390/nu12113583 · Cited by 73
Metabolic Reprogramming of Liver Fibrosis
Delgado, M. E., Cárdenas, B. I., Farran, N., & Fernandez, M. (2021) · Cells · doi:10.3390/cells10123604 · Cited by 71
“Indeed, recent publications highlight the role of RNAs as important regulators of stress responses and metabolic disruptions [119,120].”
BackgroundThe interplay between obesity, immunosenescence, and insulin resistance
Shimi, G., Sohouli, M. H., Ghorbani, A., Shakery, A., & Zand, H. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00414-7 · Cited by 90
“These findings establish a correlation between cytokines produced by adipose tissue, the immune sys-tem, and insulin resistance [59].”
BackgroundHerradon, G., Ramos-Alvarez, M. P., & Gramage, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00377 · Cited by 71
“The association of insulin resistance with inflammation has been studied in depth during the last few decades (Shoelson et al., 2006; Olefsky and Glass, 2010; Hotamisligil, 2017), including the role of macrophages (Olefsky and Glass, 2010).”
BackgroundMacrophages: The Potent Immunoregulatory Innate Immune Cells
Kumar, V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88013 · Cited by 90
Zhao, Y., Wang, Q., Yan, S., Zhou, J. Y., Huang, L., Zhu, H., Ye, F., Zhang, Y., Chen, L., Chen, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.659215 · Cited by 84
“…speck-like protein containing a caspase recruitment domain, and caspase-1, which can be activated under metabolic stress by damageassociated molecular patterns including high glucose (HG), palmitate, cholesterol crystals, uric acid, ceramide and C-reactive protein (Hotamisligil, 2017).”
BackgroundGong, J., Gao, X., Ge, S., Li, H., Wang, R., & Zhao, L. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84890 · Cited by 77
“Ultimately, this disruption leads to the development of metabolic diseases [13].”
Backgroundvan Dierendonck, X. A. M. H., Rodriguez, M. A. D. L. R., Georgiadi, A., Mattijssen, F., Dijk, W., van Weeghel, M., Singh, R., Borst, J. W., Stienstra, R., & Kersten, S. (2019) · Cell Reports · doi:10.1016/j.celrep.2020.01.046 · Cited by 76
Recent Updates on Obesity Treatments: Available Drugs and Future Directions
Dragano, N. R. V., Fernø, J., Diéguez, C., López, M., & Milbank, E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.034 · Cited by 85
Macrophages in pancreatic cancer: An immunometabolic perspective
Yang, J. M., Li, Y., Sun, Z., & Zhan, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.029 · Cited by 76
Peiseler, M., & Tacke, F. (2021) · Cancers · doi:10.3390/cancers13040730 · Cited by 71
“Metabolic inflammation is characterized by low grade smoldering immune activation without adequate resolution, triggered by metabolic pathways, insulin resistance and lipotoxicity [21].”
BackgroundInflammation promotes adipocyte lipolysis via IRE1 kinase
Foley, K. P., Chen, Y., Barra, N. G., Heal, M., Kwok, K., Tamrakar, A. K., Chi, W., Duggan, B. M., Henriksbo, B. D., Liu, Y., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100440 · Cited by 83
“This “metaflammation” can manifest from autocrine responses within metabolic cell types that regulate glucose and lipid metabolism (4).”
BackgroundRole of TLR4 in the induction of inflammatory changes in adipocytes and macrophages
McKernan, K. E., Varghese, M., Patel, R. R., & Singer, K. (2020) · Adipocyte · doi:10.1080/21623945.2020.1760674 · Cited by 78
“[21,23,24] and chemokines such as MCP1 [25,26] that are important contributors to insulin resistance and overall metabolic syndrome in obesity [7,27].”
BackgroundNew Insights into Adipose Tissue Macrophages in Obesity and Insulin Resistance
Cai, Z., Huang, Y., & He, B. (2022) · Cells · doi:10.3390/cells11091424 · Cited by 78
Kuneman, J. H., Rosendael, S. E. V., van der Bijl, P., van Rosendael, A. R., Kitslaar, P. H., Reiber, J. H. C., Jukema, J. W., Leon, M. B., Marsan, N. A., Knuuti, J. M., et al. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.122.014672 · Cited by 73
“Subtotal/occluded (≥90%) 10 (5) 9 (14) 1 (1)”
Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders
van den Brink, W., van Bilsen, J. H. M., Salic, K., Hoevenaars, F. P. M., Verschuren, L., Kleemann, R., Bouwman, J., Ronnett, G. V., van Ommen, B., & Wopereis, S. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00129 · Cited by 81
“Since metabolism and the innate immune system are closely connected [for review, see (5, 7)], interception could focus on metabolism as well as on inflammation dynamics to restore disbalances.”
BackgroundInfluentialKigerl, K. A., Zane, K., Adams, K., Sullivan, M. B., & Popovich, P. G. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113085 · Cited by 72
“Since immune and metabolic processes are normally tightly coupled and are essential for life (Hotamisligil, 2017a, 2017b), most, if not all, co-morbidities that affect SCI individuals (e.g., spontaneous infections in lung or skin, impaired wound healing, non-alcoholic fatty liver disease, chronic…”
BackgroundWiȩckowska-Gacek, A., Mietelska-Porowska, A., Chutorański, D., Wydrych, M., Długosz, J., & Wojda, U. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.654509 · Cited by 71
“…immune cells to free fatty acids initiates pro-inflammatory signaling pathways (Lyons et al., 2016) resulting in the secretion of pro-inflammatory agents from adipocytes and resident immune cells leading to lipotoxicity and insulin resistance (Hotamisligil, 2017; Burhans et al., 2019).”
BackgroundKuang, S., He, F., Liu, G., Sun, X.-Z., Dai, J., Chi, A., Tang, Y., Li, Z., Gao, Y., Deng, C., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120963 · Cited by 70
Tomé, D. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00943-0 · Cited by 79
Cheng, F., Wang, S., Zheng, H., Shen, H., Zhou, L., Yang, Z., Li, Q., Zhang, Q., & Zhang, H. (2022) · Small Methods · doi:10.1002/smtd.202200949 · Cited by 72
Vivarelli, S., Costa, C., Teodoro, M., Giambò, F., Tsatsakis, A. M., & Fenga, C. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03391-2 · Cited by 77
“Although the causes behind the insurgence of NCDs are multiple (and usually difficult to dissect), the common feature of all these chronic pathologies is a low-grade, systemic and subclinical inflammatory status, called metaflammation, which worsens with aging (Hotamisligil 2017).”
BackgroundA Unique Population: Adipose-Resident Regulatory T Cells
Zeng, Q., Sun, X., Xiao, L., Xie, Z., Bettini, M., & Deng, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02075 · Cited by 70
“Function Metabolic disorders are associated with and mediated by inflammatory processes (20, 21).”
BackgroundRecent advances in the pathogenesis of microvascular complications in diabetes
Park, S., Kang, H., Jeon, J., Kim, M., & Lee, I. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01130-3 · Cited by 77
Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects
Biobaku, F., Ghanim, H., Monte, S. V., Caruana, J. A., & Dandona, P. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa049 · Cited by 68
“Several other inflammatory mediators such as protein kinase Cβ, Jun N-terminal kinases, IκB kinase, S6 Protein Kinase, and mammalian target of rapamycin have also been causally implicated in the development of insulin resistance in human obesity as they can interfere with insulin signal transduction at the IRS-1 level…”
BackgroundLiu, J., Li, Y., Chen, S., Lin, Y., Lai, H., Chen, B., & Chen, T. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00838 · Cited by 84
“In numerous inflammatory diseases, the presently available intervention approaches have limited or no success (Hotamisligil, 2017); hence, we require new methods of treating chronic inflammatory diseases.”
Malignant JAK-signaling: at the interface of inflammation and malignant transformation
Perner, F., Pahl, H. L., Zeiser, R., & Heidel, F. H. (2025) · Leukemia · doi:10.1038/s41375-025-02569-8 · Cited by 77
Treatment of Hypertension in Patients with Asthma
Christiansen, S. C., & Zuraw, B. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1800345 · Cited by 76
Gong, J., Li, J., Dong, H., Chen, G., Qin, X., Hu, M., Yuan, F., Fang, K., Wang, D., Jiang, S., et al. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2710-6 · Cited by 76
Faghfouri, A. H., Zarezadeh, M., Tavakoli‐Rouzbehani, O. M., Radkhah, N., Faghfuri, E., Kord‐Varkaneh, H., Tan, S. C., & Ostadrahimi, A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173368 · Cited by 77
Adipocyte IRE1α promotes PGC1α mRNA decay and restrains adaptive thermogenesis
Chen, Y., Wu, Z., Huang, S., Wang, X., He, S., Liu, L., Hu, Y., Chen, L., Chen, P., Liu, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00631-8 · Cited by 78
Neutrophils’ Contribution to Periodontitis and Periodontitis-Associated Cardiovascular Diseases
Bassani, B., Cucchiara, M., Butera, A., Kayali, O., Chiesa, A., Palano, M. T., Olmeo, F., Gallazzi, M., Dellavia, C. P. B., Mortara, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015370 · Cited by 79
Zikou, E., Koliaki, C. C., & Makrilakis, K. (2024) · Biomedicines · doi:10.3390/biomedicines12081871 · Cited by 81
“Obesity has been consistently associated with chronic low-grade inflammation, induced in response to excess nutrient availability [4,5].”
BackgroundPlasma protein N-glycan signatures of type 2 diabetes
Dotz, V., Lemmers, R. F. H., Reiding, K. R., Ederveen, A. L. H., Lieverse, A. G., Mulder, M. T., Sijbrands, E. J. G., Wuhrer, M., & van Hoek, M. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.08.005 · Cited by 71
Adipose tissue, immune aging, and cellular senescence
Frasca, D., & Blomberg, B. B. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00812-1 · Cited by 78
“ABCs express low levels of the anti-oxidant enzyme superoxide dismutase-1, which is antiinflammatory and decreases ROS production and oxidative stress [156].”
BackgroundInfluentialGut Microbiome Changes in Gestational Diabetes
Ionescu, R. F., Enache, R. M., Creţoiu, S. M., & Gașpar, B. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112839 · Cited by 73
“The interactions between immune and parenchymal cells in very active organs with metabolic roles play important parts in the development of metabolic disorders [81].”
BackgroundYan Fang, G. O. N. G., Li, G., Tao, J., Wu, N. N., Kandadi, M. R., Bi, Y., Wang, S., Pei, Z., & Ren, J. T. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165855 · Cited by 70
Buicu, A., Cernea, S., Benedek, I., Buicu, C.-F., & Benedek, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081545 · Cited by 73
Diabetic sarcopenia: metabolic and molecular appraisal
Giha, H. A., Alamin, O. A. O., & Sater, M. S. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01883-2 · Cited by 71
“The disturbed immunometabolic balance observed in chronic T2DM and obesity can be explained by insufficiency of this immune/metabolic cross-talk signaling factors such as insulin receptors [53], inflammasome, TNFα, and other cytokines [54].”
BackgroundHeavy arch: from inflammatory bowel diseases to metabolic disorders
Adolph, T. E., Meyer, M., Jukic, A., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2024-331914 · Cited by 74
Mirabelli, M., Misiti, R., Sicilia, L., Brunetti, F. S., CHIEFARI, E. D., Brunetti, A., & FOTI, D. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189802 · Cited by 76
“The discovery in 1987 of adipsin, an adipocyte-specific protein, and later leptin in 1994, marked a shift in understanding adipose tissue as a true endocrine organ [8].”
BackgroundClemente‐Suárez, V. J., Martín-Rodríguez, A., Beltrán-Velasco, A. I., Rubio-Zarapuz, A., Martínez‐Guardado, I., Valcárcel‐Martín, R., & Tornero-Aguilera, J. F. (2025) · Antioxidants · doi:10.3390/antiox14060725 · Cited by 81
Faria, S. S., Corrêa, L. H., Cardoso, G. S. H. R., de Sant’Ana, L. P., Almeida, R. D. N., & Magalhães, K. G. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e35 · Cited by 74
“However, experimental data suggest that during tumor initiation, proinflammatory macrophages might promote malignant transformation through mutagenic reactive species of oxygen and nitrogen [74].”
BackgroundAdipokines in the Skin and in Dermatological Diseases
Kovács, D., Fazekas, F., Oláh, A., & Törőcsik, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239048 · Cited by 72
“Alterations in the number of WAT cells and their dysregulated functions, therefore results in the pathogenesis of various diseases such as obesity, insulin resistance, type 2 diabetes, cardiovascular diseases [6,7] but may also be involved in “non-typical metabolic diseases” such as psoriasis [8,9].”
BackgroundGalvagno, S. M., Pelekhaty, S. L., Cornachione, C. R., Deatrick, K. B., Mazzeffi, M. A., Scalea, T. M., & Menaker, J. A. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004454 · Cited by 66
FABP7 upregulation induces a neurotoxic phenotype in astrocytes
Killoy, K. M., Harlan, B. A., Pehar, M., & Vargas, M. R. (2020) · Glia · doi:10.1002/glia.23879 · Cited by 67
“Fatty acid-dependent enzy- matic and transcriptional networks induce gene expression changes that ultimately modulate cell growth, metabolism, and inflammatory responses (Hotamisligil, 2017; Hotamisligil & Erbay, 2008).”
BackgroundBreaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Visceral adiposity, inflammation, and hippocampal function in obesity
Stranahan, A. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108920 · Cited by 74
Origin and Development of the Adipose Tissue, a Key Organ in Physiology and Disease
Parra-Peralbo, E., Talamillo, A., & Barrio, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.786129 · Cited by 69
“In spite of the fact that most of the functional studies in Drosophila are conducted at larval stages, there are enough evidences to ensure that the adult FB carries out liver, adipose, and immune functions (Hotamisligil, 2017; Arrese and Soulages, 2010).”
BackgroundInfluentialNeuroprotective Role of Lactoferrin during Early Brain Development and Injury through Lifespan
Schirmbeck, G. H., Sizonenko, S. V., & Sanches, E. F. (2022) · Nutrients · doi:10.3390/nu14142923 · Cited by 70
Lucht, S. A., Hennig, F., Moebus, S., Führer‐Sakel, D., Herder, C., Jöckel, K., & Hoffmann, B. H. (2019) · Environment International · doi:10.1016/j.envint.2019.01.005 · Cited by 63
“Inflammation-induced activation of these cascades, such as the c-Jun N-terminal kinase (JNK) or IκB kinase (IKK)/NF-κB pathways, has been shown to lead to inhibition of insulin action (Hotamisligil, 2017; Lontchi-Yimagou et al., 2013).”
BackgroundInfluentialHernández‐Cáceres, M. P., Toledo, L., Díaz‐Castro, F., Ávalos, Y., Burgos, P., Narro, C., Peña‐Oyarzún, D., Espinoza-Caicedo, J., Cifuentes-Araneda, F., Navarro-Aguad, F., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00176 · Cited by 71
Harbeson, D. J., Francis, F., Bao, W., Amenyogbe, N., & Kollmann, T. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01918 · Cited by 69
Morano, A. E. V. A., Dorneles, G. P., Peres, A., & Lira, F. S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29228 · Cited by 73
“…diseases widely discussed in the literature, such as obesity, type 2 diabetes mellitus, hypertension, dyslipidemias, and cardiovascular diseases (Chatzigeoegiou et al., 2013; Pedersen, 2009; Petersen & Pedersen, 2005; Hotamisligil, 2017; Wensveen, Valentić, Šestan, Turk Wensveen, & Polić, 2015).”
BackgroundInfluentialAdipocytes: active facilitators in epithelial ovarian cancer progression?
Dai, L., Song, K., & Di, W. J. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00718-4 · Cited by 66
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Hoel, F., Hoel, A., Pettersen, I. K. N., Rekeland, I. G., Risa, K., Alme, K., Sørland, K., Fosså, A., Lien, K., Herder, I., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.149217 · Cited by 68
“The 2 most distinct ME/CFS metabotypes, ME-M1 and ME-M2, aligned with well-known phenotypes of chronic diseases with immuno-metabolic projections (34, 37, 38).”
BackgroundInfluentialTargeting GM-CSF in inflammatory and autoimmune disorders
Achuthan, A. A., Lee, M.-C., & Hamilton, J. A. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101523 · Cited by 71
A gerophysiology perspective on healthy ageing
Kémoun, P., Ader, I., Planat‐Benard, V., Dray, C., Fazilleau, N., Monsarrat, P., Cousin, B., Paupert, J., Ousset, M., Lorsignol, A., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101537 · Cited by 77
Merabet, N., Lucassen, P. J., Crielaard, L., Stronks, K., Quax, R., Sloot, P. M. A., la Fleur, S. E., & Nicolaou, M. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100972 · Cited by 87
“Obesity-driven inflammation is therefore thought to result from an imbalance between M1 and M2 macrophages, induced by conditions arising from excess adipose tissue accumulation (Castoldi et al., 2016; Catrysse and van Loo, 2018; Hotamisligil, 2017).”
InfluentialMany, G. M., Sanford, J. A., Sagendorf, T. J., Hou, Z., Nigro, P., Whytock, K. L., Amar, D., Caputo, T., Gay, N. R., Gaul, D. A., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00959-9 · Cited by 65
Recent advances in the effect of adipose tissue inflammation on insulin resistance
Yan, K. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111229 · Cited by 70
Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer
Cha, Y. J., Kim, E.-S., & Koo, J. S. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4722-1 · Cited by 66
Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting
Kumar, V. (2018) · Inflammation · doi:10.1007/s10753-018-0939-8 · Cited by 71
“) situations that determines their destiny [68, 69] and (b) Tissue immunometabolism that mainly deals with the impact of the immune cells on tissue and systemic metabolism that favors the required transformation of an individual or an o r g a n i sm t o e n v i r o nmen t a l c h a n g e s [ 6 7 ] .”
BackgroundInflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
Myint, M., Oppedisano, F., De Giorgi, V., Kim, B.-M., Marincola, F. M., Alter, H. J., & Nesci, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04627-0 · Cited by 61
“Inflammation arising in a state of over-nutrition and excessive lipid storage without infection is termed “ metabolic inflammation ” [56], where imbalances in mitochondrial ROS production cause oxidative stress and lipotoxicity, leading to mitochondrial DNA damage, lipid peroxidation, and the…”
BackgroundThe Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
Engelmann, C., & Tacke, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020652 · Cited by 61
“Hepatocyte fat accumulation and inflammation are the main drivers of disease progression [12,13] and the subsequent hepatocellular injury is characterized by alterations of the cellular function.”
BackgroundAlphavirus-induced hyperactivation of PI3K/AKT directs pro-viral metabolic changes
Mazzon, M., Castro, C., Thaa, B., Liu, L., Mutso, M., Liu, X., Mahalingam, S., Griffin, J. L., Marsh, M., & McInerney, G. M. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006835 · Cited by 61
“The immune system itself, central for host defence from pathogens, is highly dependent on the metabolic activity of the organism for critical processes such as cell proliferation and differentiation [1].”
BackgroundImmunometabolism and metainflammation in obesity
Romantsova, T. I., & Sych, Y. P. (2019) · Obesity and metabolism · doi:10.14341/omet12218 · Cited by 69
Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota
Golonka, R. M., Xiao, X., Abokor, A. A., Joe, B., & Vijay–Kumar, M. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108360 · Cited by 61
Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia
Zhou, W., Ye, S., Wang, W., Li, S., Hu, Q., & Masaki, T. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3918723 · Cited by 61
“An aetiopathological role of inflammation in the development and progression of T2DM is increasingly accepted [25, 26], inflammatory cytokines can cause both structural and functional abnormities in endothelial cells leading to the dysfunction of insulin secretion and the damage of islet β cells, which will eventually…”
BackgroundFeijóo‐Bandín, S., Aragón‐Herrera, A., Otero-Santiago, M., Anido‐Varela, L., Moraña‐Fernández, S., Tarazón, E., Roselló‐Lletí, E., Portolés, M., Gualillo, O., González‐Juanatey, J. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105634 · Cited by 63
Yang, Y., & Liu, A. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02945-9 · Cited by 74
“Research has shown a significant interaction between inflammation and IR [10], suggesting that relying on a single biomarker may underestimate the true risk.”
Enzyme-responsive biomaterials for biomedical applications
Pi, Y., Ganabady, K., & Celiz, A. D. (2025) · Communications Materials · doi:10.1038/s43246-025-00983-0 · Cited by 66
“In fl ammation, whether acute or chronic, is a critical immune response that supports tissue repair, remodeling, and regeneration 98 .”
Motterlini, R., Nikam, A. P., Manin, S., Ollivier, A., Wilson, J. L., Djouadi, S., Muchová, L., Martens, T., Rivard, M., & Foresti, R. (2018) · Redox Biology · doi:10.1016/j.redox.2018.10.020 · Cited by 66
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
Ramalho, R., Rao, M., Zhang, C., Agrati, C., Ippolito, G., Wang, F., Zumla, A. I., & Maeurer, M. J. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00798-w · Cited by 70
ElMahdy, M. K., Helal, M. G., & Ebrahim, T. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106730 · Cited by 63
Bhandarkar, N. S., Mouatt, P., Majzoub, M. E., Thomas, T., Brown, L., & Panchal, S. K. (2021) · Pathogens · doi:10.3390/pathogens10111369 · Cited by 65
The stress-responsive protein REDD1 and its pathophysiological functions
Kim, J., Kwon, Y., & Kim, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01056-3 · Cited by 255
Autolysosomal Dysfunction in Obesity-induced Metabolic Inflammation and Related Disorders
Cheong, L. Y. T., Saipuljumri, E. N., Loi, G. W. Z., Zeng, J., & Lo, C. H. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00638-8 · Cited by 69
A Complex Relationship between Immunity and Metabolism in Drosophila Diet-Induced Insulin Resistance
Musselman, L. P., Fink, J. L., Grant, A. R., Gatto, J. A., Tuthill, B. F., & Baranski, T. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00259-17 · Cited by 69
Zheng, C., Wu, A., Zhai, X., Ji, H., Chen, Z., Chen, X., & Yu, X. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.021 · Cited by 60
Rahim, R. A., Jayusman, P. A., Muhammad, N., Mohamed, N., Lim, V., Ahmad, N. H., Mohamad, S., Hamid, Z. A. A., Ahmad, F., Mokhtar, N. M., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073532 · Cited by 72
Biomarkers of dysfunctional visceral fat
Gugliucci, A. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.03.001 · Cited by 73
Automated design of multi-target ligands by generative deep learning
Isigkeit, L., Hörmann, T., Schallmayer, E., Scholz, K., Lillich, F. F., Ehrler, J. H. M., Hufnagel, B., Büchner, J., Marschner, J. A., Pabel, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52060-8 · Cited by 71
Brénachot, X., Ramadori, G., Ioris, R. M., Veyrat‐Durebex, C., Altirriba, J., Aras, E., Ljubicic, S., Kohno, D., Fabbiano, S., Clément, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02074-2 · Cited by 64
IL-29 promoted obesity-induced inflammation and insulin resistance
Lin, T.-Y., Chiu, C.-J., Kuan, C., Chen, F. H., Shen, Y.-C., Wu, C., & Hsu, Y. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0262-9 · Cited by 62
Role of Flavonoids in the Interactions among Obesity, Inflammation, and Autophagy
García‐Barrado, M. J., Osma, M. D. C. I., García, E. P., Carrero, S., Blanco, E. J., Carretero‐Hernández, M., & Carretero, J. (2020) · Pharmaceuticals · doi:10.3390/ph13110342 · Cited by 64
“Inflammation commonly seen in obese and overweight patients is described as meta-inflammation: chronic and low-grade inflammation response [30,32].”
Background
Metadata
- Authors
- Hotamisligil, G. S.
- Venue
- Nature
- Published
- 2017-02-09
- Volume
- 542
- Issue
- 7640
- Pages
- 177-185
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2587680743
- Cited by
- 2,570
- References
- 144
- Citations by year
- 2026: 501 · 2025: 322 · 2024: 264 · 2023: 253 · 2022: 252 · 2021: 296 · 2020: 283 · 2019: 217 · 2018: 125 · 2017: 57
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Servier
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL125753)
- National Institute of Allergy and Infectious Diseases (R01AI116901)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK052539)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- inflammation, metabolic inflammation, immunometabolism, obesity, metabolic disorders, adipose tissue inflammation, non-communicable diseases, diabetes mellitus
- MeSH terms
- Animals, Clinical Trials as Topic, Hormones, Humans, Inflammation, Invertebrates, Metabolic Diseases, Obesity, Organelles, Signal Transduction, Cytokines, Evolution, Molecular, Genome-Wide Association Study, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.